Kinetic analysis of transport and hydrolysis of dipeptides, a new osmotic agent for peritoneal dialysis solution

• Autorzy: Weryński A. , Waniewski J. , Wang T. , Anderstam B. , Lindholm B. , Bergström J.
• Języki publikacji: EN

Abstrakty

EN

A mixture of dipeptides (DP) have been proposed as an alternative (to glucose and amino acids, AA) osmotic agent in peritoneal dialysis (PD) solutions. The following solutions were used: (1) the amino acids (AA) solution containing leucine, valine, lysine, isoleucine, threonine, phenylalanine and histidine (tyrosine was omitted because of its poor solubility), (2) the dipeptide (DP) solution containing leucyl-valine, lysyl-isoleucine, threonyl-phenylalanine and histidyl-tyrosine. Sixteen Sprague-Dawley rats were used in the experiments. Kinetic models were developed for estimation of the diffusive mass transport coefficient between the peritoneal cavity and blood (KBD), the DP hydrolysis rate coefficient (KH ) and the AA clearance in the body (KC). The calculations show that KH is about ten times smaller than KBD. Thus, the hydrolysis rate in the peritoneal cavity is much smaller than the diffusive transport rate of DP. KBD for AA appeared to be similar to KBD for dipeptides. KC was much higher than KBD for AA. This finding explains the rapid clearance of amino acids from blood. The peritoneal transport characteristics of AA and DP were similar; however, their kinetics in blood considerably differed. The DP solution resulted in a less pronounced increase of the AA concentrations in blood, suggesting that the DP solution could provide the AA supply/delivery in a more physiological way.

Słowa kluczowe

EN

dipeptides; amino acids; peritoneal dialysis solution

PL

dwupeptyd; aminokwas; dializa otrzewnowa

• Wydawca: Nałęcz Institute of Biocybernetics and Biomedical Engineering of the Polish Academy of Sciences ; Elsevier
• Czasopismo: Biocybernetics and Biomedical Engineering
• Rocznik: 2007
• Tom: Vol. 27, no. 1-2
• Strony: 71--82
• Opis fizyczny: Bibliogr. 23 poz., rys., tab.

Twórcy

autor

Weryński A.

autor

Waniewski J.

autor

Wang T.

autor

Anderstam B.

autor

Lindholm B.

autor

Bergström J.

• Institute of Biocybemetics and Biomedical Engineering, Polish Academy of Science, 4 Ks. Trojdena St., 02-109 Warsaw, Poland,

Bibliografia

• 1. Lindholm B., Park M.S., Bergstrom J.: Supplemented dialysis: amino acid-based solutions in peritoneal dialysis. Contributions to Nephrology 1993, 103, 168-182.
• 2. Kopple J.D., Bernard D., Messana J., Swartz R., Bergstrom J., Lindholm B., Lim V., Brunori G., Leiserowitz M., Bier D.M., et al.: Treatment of malnourished CAPD patients with an amino acid based dialysate. Kidney Int., 1995,47(4), 1148-1157.
• 3. Garosi G., Gaggiotti E., Monaci G., Brardi S., Di Paolo N.: Biocompatibility of a peritoneal dialysis solution with amino acids: histological evaluation in the rabbit. Peril. Dial. Int., 1998, 18(6), 610-619.
• 4. Mamoun A.H., Anderstam B., Soderstein P., Lindholm B., Bergstrom J.: Influence of peritoneal dialysis solutions with glucose and amino acids on ingestive behaviour in rats. Kidney Int., 1996, 49, 1276-1282.
• 5. Jones M., Martis L., Algrim C.E., Bernard D., Swartz R., et al.: Amino acid solutions for CAPD: Rationale and clinical experience. Miner. Electrolyte. Metab. 1992, 18, 309-315.
• 6. Jones M., Hagen T., Boyle C., Vonesh E., Hamburger R., Charytan C. et al.: Treatment of malnutrition with 1.1% amino acid peritoneal dialysis solution: results of multicenter outpatient study. Am. J. Kidney Dis. 1998, 32, 5, 761-769.
• 7. Young G.A., Parsons P.M.: Impairment of phenylalanine hydroxylation in chronic renal insufficiency. Clin. Sci., 1973,45(1), 89-97.
• 8. Furst P., Albers S., Stehle P.: Dipeptides in clinical nutrition. Proc. Nutr. Soc., 1990, 49(3), 343-359.
• 9. Avraham Y, Hao S., Mendelson S., Berry E.: Tyrosine improves appetite, cognition, and exercise tolerance in activity anorexia. Med. Sci. Sport. Exerc., 2001, 33 (12), 2104-2110.
• 10. Druml W., Lochs H., Roth E., Hubl W., Balcke P., Lenz K.: Utilization of tyrosine dipeptides and acetyltyrosine in normal and uremic humans. Am. J. Physiol., 1991, 260 (2 Pt 1), E280-5.
• 11. Grimble G.K.: The significance of peptides in clinical nutrition. Annu. Rev. Nutr., 1994,14,419-447.
• 12. Suliman M.E., Anderstam B., Bergstrom J.: Evidence of taurine depletion and accumulation of cysteinesulfinic acid in chronic dialysis patients. Kidney Int., 1996, 50(5), 1713-1717.
• 13. Waniewski J., Weryński A., Heimburger O., Lindholm B.: Simple membrane models for peritoneal dialysis. Evaluation of diffusive and convective solute transport. ASAIO J., 1992, 38(4), 788-796.
• 14. Waniewski J., Heimburger O., Weryński A., Lindholm B.: Aqueous solute concentrations and evaluation of mass transport coefficients in peritoneal dialysis. Nephrol. Dial. Transplant., 1992, 7(1), 50-56.
• 15. Waniewski J., Heimburger O., Park M.S., Weryński A., Lindholm B.: Methods for estimation of peritoneal dialysate volume and reabsorption rate using macromolecular markers. Peril. Dial. Int., 1994, 14(1), 8-16.
• 16. Waniewski J., Heimburger O., Park M.S., Weryński A., Lindholm B.: Bidirectional solute transport in peritoneal dialysis. Perit. Dial. Int., 1994, 14(4), 327-337.
• 17. Wang T, Qureshi A.R., Heimburger O., Waniewski J., Bergstrom J., Lindholm B.: Daily exposure to dialysis fluid results in changes in peritoneal transport. Perit. Dial. Int., 1997, 17(4), 379-386.
• 18. Weryński A., Waniewski J., Wang T., Anderstam B., Linholm B., Bergstrom J.: Kinetic studies of di-peptide-based and amino acid-based peritoneal dialysis solutions. Kidney Int., 2001, 59, 363-371.
• 19. de la Motte S., Plum J., Passlick-Deetjen J., Grabensee B: One-compartment model for amino acids and other biological molecules in peritoneal dialysis. Int. J. Clinical Pharmacology and Therapeutics, 2002, 40(2), 60-68.
• 20. Wang T., Cheng H. H., Guo Q. Y, Lindholm B.: Intraperitoneal (IP) use of pentobarbital (PB) changes peritoneal transport. Perit. Dial. Int., 2000,20 (Suppl. 1), 516.
• 21. Kee A.J., Smith R.C., Gross A.S., Madsen D.C., Rowe B.: The effect of dipeptide structure on di-peptide and amino acid clearance in rats. Metabolism 1994, 43(11), 1373-1378.
• 22. Waniewski J., Heimburger O., Weryński A., LindholmB.: Paradoxes in peritoneal transport of small solutes. Perit. Dial. Int., 1996, 16 (Suppl. 1), S63-S69.
• 23. Weryński A., Waniewski J., Wang B., Anderstam B., Lindholm B., Berstrom J.: Comparison of kinetic characteristics of dialysis with amino acid-based and dipeptide-based peritoneal dialysis solutions. Int. J. Artif. Organs, 29, 7, 2006, 681-690.